Early Phase 2 data published in the New England Journal of Medicine in 2023 showed considerable promise, but retatrutide has not yet received approval from the MHRA or EMA
5,6 In addition, receptor activator of nuclear factor kappa beta ligand (RANKL), that plays a crucial role in osteoclast activity and bone resorption, 21 also directly influences pancreatic beta-cell function and overall metabolism, with its activity being compromised in obesity and T2D
New CV indication for Wegovy ( NICE, April 2026 ): Adults with cardiovascular diseases like previous heart attack, stroke, or peripheral arterial disease, etc
That includes physiological symptoms, the emotional impact of those symptoms, access to information and resources, access to expertise, and more
Residual solvent screening matters more here than for peptides because of the synthesis process
FDA Approval of Semaglutide for MASH Marks a Turning Point in Liver Care A Global Burden: MASLD and MASH Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD, affects roughly 30% of adults worldwide